Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2008

01-02-2008 | Original Paper

Delayed Complications after Placement of Self-Expanding Stents in Malignant Esophageal Obstruction: Treatment Strategies and Survival Rate

Authors: Nils Homann, Maria R. Noftz, Rolf D. Klingenberg-Noftz, Diether Ludwig

Published in: Digestive Diseases and Sciences | Issue 2/2008

Login to get access

Abstract

Purpose

Placement of self-expanding metal stents is regarded as a safe and effective treatment in patients with incurable malignant esophagogastric obstruction. However, proceeding and possible benefit of re-interventions in patients with recurrent dysphagia due to delayed complications (>4 weeks after stent insertion) is unclear.

Patients and methods

In 133 patients with malignant stricture of the esophagus or the esophagogastric junction 164 expandable metal stents were placed. About 89 patients were followed up until death. All tumor- or stent-related complications and consequent re-interventions were recorded.

Results

The overall incidence of delayed complications was 53.4% (71 of 133 pts.), with 34 patients (25.6%) experiencing more than one complication. Recurrent dysphagia due to tumor ingrowth (22%) or overgrowth (15%), bolus obstruction (21%), stent migration (9%), and development of esophagorespiratory fistula (9%) was successfully treated by dilatation (24%), placement of a second/third stent (27%), laser therapy (16%), and/or placement of a feeding tube (PEG, 19%). The median survival of patients with endoscopic therapy was significantly longer (222 ± 26 days) compared to patients without re-intervention (86 ± 14 days, P < 0.0001).

Conclusions

Delayed complications after metal stent placement for malignant esophageal stricture are common, but can be treated successfully by endoscopic re-intervention in most cases. Regular interventional therapy may also improve survival.
Literature
1.
go back to reference Blot WJ, MwcLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26:2–8PubMed Blot WJ, MwcLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26:2–8PubMed
2.
go back to reference Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681–1687PubMedCrossRef Baron TH (2001) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681–1687PubMedCrossRef
3.
go back to reference Cwikiel M, Cwikiel W, Albertsson M (1996) Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol 35:75–79PubMedCrossRef Cwikiel M, Cwikiel W, Albertsson M (1996) Palliation of dysphagia in patients with malignant esophageal strictures. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol 35:75–79PubMedCrossRef
4.
go back to reference Ell C, May A (1997) Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: a critical review. Endoscopy 29:392–398PubMed Ell C, May A (1997) Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: a critical review. Endoscopy 29:392–398PubMed
5.
go back to reference Homs MY, Siersema PD (2001) Self-expanding metal stents or conventional prostheses for palliation of dysphagia? Endoscopy 33:466–467PubMed Homs MY, Siersema PD (2001) Self-expanding metal stents or conventional prostheses for palliation of dysphagia? Endoscopy 33:466–467PubMed
6.
go back to reference Kozarek RA (1999) Complications and lessons learned from 10 years of expandable gastrointestinal prostheses. Dig Dis 17:14–22PubMedCrossRef Kozarek RA (1999) Complications and lessons learned from 10 years of expandable gastrointestinal prostheses. Dig Dis 17:14–22PubMedCrossRef
7.
go back to reference Shimi SM (2000) Self-expanding metallic stents in the management of advanced esophageal cancer: a review. Semin Laparosc Surg 7:9–21PubMed Shimi SM (2000) Self-expanding metallic stents in the management of advanced esophageal cancer: a review. Semin Laparosc Surg 7:9–21PubMed
8.
go back to reference Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, Dees J (2001) Rotterdam esophageal tumor study group. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 54:579–586PubMedCrossRef Siersema PD, Schrauwen SL, van Blankenstein M, Steyerberg EW, van der Gaast A, Tilanus HW, Dees J (2001) Rotterdam esophageal tumor study group. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 54:579–586PubMedCrossRef
9.
go back to reference Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD (2001) Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 12:465–474PubMedCrossRef Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD (2001) Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 12:465–474PubMedCrossRef
10.
go back to reference Kozarek RA, Ball TJ, Brandabur JJ, Patterson DJ, Low D, Hill L, Raltz S (1996) Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 43:204–208PubMedCrossRef Kozarek RA, Ball TJ, Brandabur JJ, Patterson DJ, Low D, Hill L, Raltz S (1996) Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 43:204–208PubMedCrossRef
11.
go back to reference Ludwig D, Dehne A, Burmester E, Wiedemann GJ, Stange EF (1998) Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 13:583–588PubMed Ludwig D, Dehne A, Burmester E, Wiedemann GJ, Stange EF (1998) Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 13:583–588PubMed
12.
go back to reference Dorta G, Binek J, Blum AL, Buhler H, Felley CP, Koelz HR, Lammer F, Lang C, Meier R, Meyenberger C, Meyer-Wyss B, Michetti P, Protiva P, Scheurer U, Weber B, Wiesel P, Vogel S (1997) Comparison between esophageal Wallstent and Ultraflex stents in the treatment of malignant stenoses of the esophagus and cardia. Endoscopy 29:149–154PubMedCrossRef Dorta G, Binek J, Blum AL, Buhler H, Felley CP, Koelz HR, Lammer F, Lang C, Meier R, Meyenberger C, Meyer-Wyss B, Michetti P, Protiva P, Scheurer U, Weber B, Wiesel P, Vogel S (1997) Comparison between esophageal Wallstent and Ultraflex stents in the treatment of malignant stenoses of the esophagus and cardia. Endoscopy 29:149–154PubMedCrossRef
13.
go back to reference Lambert R (1995) Esophageal cancer: which stent, who places it, and where? Endoscopy 27:509–511PubMed Lambert R (1995) Esophageal cancer: which stent, who places it, and where? Endoscopy 27:509–511PubMed
14.
go back to reference Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54:145–153PubMed Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, Kuipers EJ (2001) A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54:145–153PubMed
15.
go back to reference Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791–1796 PubMedCrossRef Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, Zuccaro G, Bosco JJ, Jones WF (2001) A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96:1791–1796 PubMedCrossRef
16.
go back to reference Ell C, Hochberger J, May A, Fleig WE, Hahn EG (1994) Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: preliminary clinical experiences with Wallstents. Am J Gastroenterol 89:1496–1500PubMed Ell C, Hochberger J, May A, Fleig WE, Hahn EG (1994) Coated and uncoated self-expanding metal stents for malignant stenosis in the upper GI tract: preliminary clinical experiences with Wallstents. Am J Gastroenterol 89:1496–1500PubMed
17.
go back to reference Hills KS, Chopra KB, Pal A, Westaby D (1998) Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Eur J Gastroentrol 10:371–374CrossRef Hills KS, Chopra KB, Pal A, Westaby D (1998) Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Eur J Gastroentrol 10:371–374CrossRef
18.
go back to reference Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN (2000) Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc 51:134–138PubMedCrossRef Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN (2000) Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc 51:134–138PubMedCrossRef
19.
go back to reference McManus K, Khan I, McGuigan J (2001) Self-expanding oesophageal stents: strategies for re-intervention. Endoscopy 33:601–604PubMedCrossRef McManus K, Khan I, McGuigan J (2001) Self-expanding oesophageal stents: strategies for re-intervention. Endoscopy 33:601–604PubMedCrossRef
20.
go back to reference Stange EF, Dylla J, Fleig WE (1989) Laser treatment of upper gastrointestinal tract carcinoma: determinants of survival. Endoscopy 21:254–257PubMed Stange EF, Dylla J, Fleig WE (1989) Laser treatment of upper gastrointestinal tract carcinoma: determinants of survival. Endoscopy 21:254–257PubMed
21.
go back to reference Conio M, Caroli-Bosc F, Maes B, Pugliese V, Demarquay JF, Dumas R, Bellon S, Delmont J (1996) Early migration of a covered self-expanding metal stent corrected by implantation of a second stent. Am J Gastroenterol 91:2212–2214PubMed Conio M, Caroli-Bosc F, Maes B, Pugliese V, Demarquay JF, Dumas R, Bellon S, Delmont J (1996) Early migration of a covered self-expanding metal stent corrected by implantation of a second stent. Am J Gastroenterol 91:2212–2214PubMed
22.
go back to reference De Palma GD, Iovino P, Catanzano C (2001) Distally migrated esophageal self-expanding metal stents: wait and see or remove? Gastrointest Endosc 53:96–98PubMedCrossRef De Palma GD, Iovino P, Catanzano C (2001) Distally migrated esophageal self-expanding metal stents: wait and see or remove? Gastrointest Endosc 53:96–98PubMedCrossRef
23.
go back to reference Shim CS, Cho YD, Moon JH, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS (2001) Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration. Endoscopy 33:843–848PubMedCrossRef Shim CS, Cho YD, Moon JH, Kim JO, Cho JY, Kim YS, Lee JS, Lee MS (2001) Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration. Endoscopy 33:843–848PubMedCrossRef
24.
go back to reference Nomori H, Horio H, Imazu Y, Suemasu K (2000) Double stenting for esophageal and tracheobronchial stenoses. Ann Thorac Surg 70:1803–1807PubMedCrossRef Nomori H, Horio H, Imazu Y, Suemasu K (2000) Double stenting for esophageal and tracheobronchial stenoses. Ann Thorac Surg 70:1803–1807PubMedCrossRef
25.
go back to reference Cook TA, Dehn TC (1996) Use of covered expandable metal stents in the treatment of oesophageal carcinoma and tracheo-oesophageal fistula. Br J Surg 83:1417–1418PubMedCrossRef Cook TA, Dehn TC (1996) Use of covered expandable metal stents in the treatment of oesophageal carcinoma and tracheo-oesophageal fistula. Br J Surg 83:1417–1418PubMedCrossRef
26.
go back to reference Raijman I, Siddique I, Ajani J, Lynch P (1998) Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 48:172–179PubMedCrossRef Raijman I, Siddique I, Ajani J, Lynch P (1998) Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 48:172–179PubMedCrossRef
27.
go back to reference Freitag L, Tekolf E, Steveling H, Donovan TJ, Stamatis G (1996) Management of malignant esophagotracheal fistulas with airway stenting and double stenting. Chest 110:1155–1160PubMedCrossRef Freitag L, Tekolf E, Steveling H, Donovan TJ, Stamatis G (1996) Management of malignant esophagotracheal fistulas with airway stenting and double stenting. Chest 110:1155–1160PubMedCrossRef
28.
go back to reference Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M (1998) Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 47:113–120PubMedCrossRef Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M (1998) Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 47:113–120PubMedCrossRef
29.
go back to reference Bethge N, Sommer A, von Kleist D, Vakil N (1996) A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. Gastrointest Endosc 44:283–286PubMedCrossRef Bethge N, Sommer A, von Kleist D, Vakil N (1996) A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. Gastrointest Endosc 44:283–286PubMedCrossRef
30.
go back to reference Kinsman KJ, De Gregorio BT, Katon RM, Morrison K, Saxon RR, Keller FS, Rosch J (1996) Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 43:196–203PubMed Kinsman KJ, De Gregorio BT, Katon RM, Morrison K, Saxon RR, Keller FS, Rosch J (1996) Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 43:196–203PubMed
31.
go back to reference Binkert CA, Petersen BD (2002) Two fatal complications after parallel tracheal-esophageal stenting. Cardiovasc Intervent Radiol 25:144–147PubMedCrossRef Binkert CA, Petersen BD (2002) Two fatal complications after parallel tracheal-esophageal stenting. Cardiovasc Intervent Radiol 25:144–147PubMedCrossRef
32.
go back to reference Siersema PD, Tan TG, Sutorius FF, Dees J, van Blankenstein M (1997) Massive hemorrhage caused by a perforating Gianturco-Z stent resulting in an aortoesophageal fistula. Endoscopy 29:416–420PubMed Siersema PD, Tan TG, Sutorius FF, Dees J, van Blankenstein M (1997) Massive hemorrhage caused by a perforating Gianturco-Z stent resulting in an aortoesophageal fistula. Endoscopy 29:416–420PubMed
33.
go back to reference Dirks K, Schulz T, Schellmann B, Stolte M, Lutz H (2002) Fatal Hemorrhage following perforation of the aorta by a barb of the Gianturco-Rosch esophageal stent. Z Gastroenterol 40:81–84PubMedCrossRef Dirks K, Schulz T, Schellmann B, Stolte M, Lutz H (2002) Fatal Hemorrhage following perforation of the aorta by a barb of the Gianturco-Rosch esophageal stent. Z Gastroenterol 40:81–84PubMedCrossRef
34.
go back to reference Yakami M, Mitsumori M, Sai H, Nagata Y, Hiraoka M, Nishimura Y (2003) Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer. Int J Clin Oncol 8:395–398PubMedCrossRef Yakami M, Mitsumori M, Sai H, Nagata Y, Hiraoka M, Nishimura Y (2003) Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancer. Int J Clin Oncol 8:395–398PubMedCrossRef
35.
go back to reference Maier A, Pinter H, Friehs GB, Renner H, Smolle-Juttner FM (1999) Self-expandable coated stent after intraluminal treatment of esophageal cancer: a risky procedure? Ann Thorac Surg 67:781–784PubMedCrossRef Maier A, Pinter H, Friehs GB, Renner H, Smolle-Juttner FM (1999) Self-expandable coated stent after intraluminal treatment of esophageal cancer: a risky procedure? Ann Thorac Surg 67:781–784PubMedCrossRef
36.
go back to reference Raijman I, Siddique I, Lynch P (1997) Does chemoradiation therapy increase the incidence of complications with self-expanding coated stents in the management of malignant esophageal strictures? Am J Gastroenterol 92:2192–2196PubMed Raijman I, Siddique I, Lynch P (1997) Does chemoradiation therapy increase the incidence of complications with self-expanding coated stents in the management of malignant esophageal strictures? Am J Gastroenterol 92:2192–2196PubMed
37.
go back to reference Christein JD, Hollinger EF, Millikan KW (2002) Prognostic factors associated with resectable carcinoma of the esophagus. Am Surg 68:258–262PubMed Christein JD, Hollinger EF, Millikan KW (2002) Prognostic factors associated with resectable carcinoma of the esophagus. Am Surg 68:258–262PubMed
39.
go back to reference Fein R, Kelsen DP, Geller N, Bains M, McCormack P, Brennan MF (1985) Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 56:2512–2518PubMedCrossRef Fein R, Kelsen DP, Geller N, Bains M, McCormack P, Brennan MF (1985) Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 56:2512–2518PubMedCrossRef
40.
go back to reference Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503–509PubMedCrossRef Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503–509PubMedCrossRef
Metadata
Title
Delayed Complications after Placement of Self-Expanding Stents in Malignant Esophageal Obstruction: Treatment Strategies and Survival Rate
Authors
Nils Homann
Maria R. Noftz
Rolf D. Klingenberg-Noftz
Diether Ludwig
Publication date
01-02-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-9862-9

Other articles of this Issue 2/2008

Digestive Diseases and Sciences 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.